We have been providing laboratory services to the pharmaceutical and biotech industries for over 15 years and our laboratory services extend worldwide from the United States to Asia. Since 2010, Nordic Bioscience Laboratory (NBL) has been committed to the highest level of quality with a history of reporting accurate and high-quality results and is the only laboratory offering CAP-accredited services in Scandinavia.
In that time, we have provided central laboratory services for five multinational clinical trials in North and South America, Asia and Europe, involving a total of over 10,000 subjects. Our operations are highly scalable, and our dedicated staff currently report over a test volume of 500,000 sample results per year.
We report more than 90% of all safety-related parameters in 3 days or less, with a high accuracy rate of 98.0% or more. In addition, we are enrolled in proficiency testing and maintain a correct rate of 98.0% or higher. We accomplish a sample kit turnaround with a completion rate of more than 90% within 5 working days. We ensure data transfer with 98.0% or higher accuracy meeting all contractual agreements and maintaining a lead time of 21 calendar days or less from sample arrival to our site.
Our CAP-accredited clinical laboratory provides world-class safety testing services. We offer end-to-end central laboratory services for safety testing, including custom kit building, a laboratory manual with clear instructions, study-specific kits, pre-organized and fully pre-labeled tubes with traceable barcodes, and a stringent quality control process.
Our batch size can vary depending on needs and we offer a 3-10 day turnaround time for sample kits and the possibility to resupply. We work with closely monitored and trusted global logistics providers to ensure the shipment of clinical supplies. We are committed to excellence and have a proven track record of delivering accurate and reliable safety test data to our customers. We achieve turnaround times of 3 days or less for over 90% of all safety-related parameters while maintaining a high accuracy rate of 98.0% or higher.
In addition to regular safety testing of human blood samples from clinical trials, we are the exclusive provider of Nordic Bioscience's unique biomarker assays. Our R&D department develops and markets these biomarker assays for various diseases. We specialize in biomarkers related to extracellular matrix (ECM) and collagen biology, and our products are used in both clinical and research settings (for research use only).
Our laboratory is equipped with state-of-the-art instrumentation and platforms that lead the industry. As a CAP-accredited clinical laboratory, we continuously perform biomarker testing from preclinical to Phase I-IV studies, ensuring that our clients receive high-quality and reliable data for their drug development process.
Some of the key tools at our disposal are:
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.
